David Harris University of SydneyAustralia

David Harris is Professor of Medicine Sydney University, Director Nephrology & Dialysis Western Sydney Renal Service, and NHMRC Investigator.He is Past-President of the International, Asian Pacific, and Australian & New Zealand Societies of Nephrology. Awards include Member of the Order of Australia (2019), life membership of ANZSN (2022), inaugural ANZSN Leadership Award (2021), Richard Yu Award of the Hong Kong Society of Nephrology (2017), Honorary Membership of the Japanese Society of Nephrology (2017), Distinguished Professorial Award (Sydney University, 2016), the Priscilla Kincaid-Smith Medal (2012), and the APSN Ross Bailey lectureship (2008).He has published more than 400 papers, and given more than 270 invited national and international presentations. His major clinical and research interests include progressive CKD and dialysis, and his laboratory interests are focussed on pathogenesis of and novel therapies for progressive CKD.

1 APRIL 2023

Time Session
11:45
12:45
Chih-Wei Yang Chairperson Chang Gung Memorial HospitalTaiwan
David Harris Chairperson University of SydneyAustralia
Manisha Sahay Chairperson Osmania General HospitalIndia
  • The Goal Has Always Been Reversal of Glomerular Injury: We Are Getting Closer. Roscoe R. Robinson Award
    Charles Alpers Speaker University of Washington Medical CenterUnited States
  • Q and A
  • Introduction of Schrier Award
    Manisha Sahay Speaker Osmania General HospitalIndia
  • Schrier Award Presentation
    Irma Tchokhonelidze Speaker Tbilisi State Medical University and High Medical Technology University ClinicGeorgia
  • Q and A
MR 110
13:30
14:15
David Harris Chairperson University of SydneyAustralia
Tushar Vachharajani Chairperson Cleveland Clinic Lerner College of Medicine, Glickman Urological & Kidney InstituteUnited States
  • Introduction
    David Harris Speaker University of SydneyAustralia
  • Calciphylaxis and CKD-MBD?Ongoing Challenges and Opportunities
    Ningning Wang Speaker The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province HospitalChina
  • Critical Care, POCUS and Interventional Nephrology in Egypt
    Ahmed Ibrahim Akl Speaker Dr. Soliman Fakeeh HospitalSaudi Arabia
  • The Effect of Intravenous Theophylline on Preventing Acute Kidney Injury in Sick Neonates
    Sukanya Govindan Speaker India
  • What Can the ISN Offer You?
  • Q and A
Spotlight Stage
15:45
16:45
David Harris Chairperson University of SydneyAustralia
Ikechi Okpechi Chairperson University of AlbertaCanada
Rumeyza Kazancioglu Chairperson Bezmialem Vakif University School of MedicineTurkey
  • Introduction of Fellowship Awards
  • ASSOCIATION OF CLIMATE ON END STAGE KIDNEY FAILURE IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE IN AUSTRALIA: A 30-YEAR DATABASE STUDY
    Anh Nguyen Free Communication Cho Ray HospitalVietnam
  • Q and A
  • KIDNEY FUNCTION IS A DETERMINANT OF BONE LOSS IN PATIENTS WITH MILD TO MODERATE CKD AND BONE BIOPSY PROVEN OSTEOPOROSIS
    Mohamed Abdalbary Free Communication Egypt
  • Q and A
  • EVOLUTION OF FOUR DECADES OF CHRONIC DIALYSIS TREATMENT IN URUGUAY
    Leonella Luzardo Free Communication Hospital De ClinicasNephrology CenterUruguay
  • Q and A
  • IDENTIFICATION AND MANAGEMENT OF KIDNEY DISEASE AS PART OF ROUTINE CLINICAL CARE IN LOW-RESOURCE SETTINGS: THE ISN KIDNEY CARE NETWORK PROJECT
    Sanjib Kumar Sharma Free Communication B P Koirala Insttiute of Health sciencesNepal
  • Q and A
  • E- LEARNING IN NEPHROLOGY- A WORLDWIDE SURVEY LOOKING AT PRACTICE PATTERNS AND FUTURE NEEDS
    Sibel Bek Free Communication Kocaeli University HospitalTurkey
  • Q and A
  • ANXIETY AND DEPRESSION AFTER ADVANCE CARE PLAN INTERVENTION IN HEMODIALYSIS PATIENTS, RANDOMIZED CONTROLLED TRIAL STUDY
    Narittaya Varothai Free Communication Phramongkutklao college of medicineThailand
  • Q and A
MR 110

31 MARCH 2023

Time Session
11:45
12:45
Arpana Iyengar Chairperson St. John's Medical College HospitalIndia
David Harris Chairperson University of SydneyAustralia
Robert Walker Chairperson University of OtagoNew Zealand
  • Novel Pathways Leading to Novel Therapies in CKD. Alfred Newton Richards Award
    Carol Pollock Speaker University of SydneyAustralia
  • Q and A
  • Introduction of Clinical Research Awards
  • Costs and Outcomes of Pediatric CKD (Cope) Study: Catastrophic Healthcare Expenditure, Financial Burden And Patient Outcomes In 2 Private Sector Referral Centers In India
    Priya Pais Free Communication St John's Medical College, St John's National Academy of Health SciencesIndia
  • Q and A
  • Incidence, Associated Risk Factors, and Outcomes of Pregnancy-related Acute Kidney Injury In North Central, Nigeria
    Bala Waziri Free Communication Ibrahim Badamasi Babangida Specialist Hospital, Minna , NigeriaNigeria
  • Q and A
  • Online Health Education for Patients with Kidney Disease in The Covid-19 Pandemic: A Renal Health Instagram Analysis
    Geraldo Bezerra da Silva Jr Speaker University of FortalezaBrazil
  • Q and A
MR 110
14:15
15:15
Hyeong Cheon Park Chairperson Gangnam Severance Hospital, Yonsei University College of MedicineSouth Korea
Sydney Tang Chairperson The University of Hong KongHong Kong, China
  • President APSN - Introduction of Kenzo Oshima Award
    Sydney Tang Speaker The University of Hong KongHong Kong, China
  • Kenzo Oshima Award
    David Harris Speaker University of SydneyAustralia
  • President APSN - Introduction of Excellence in Basic Science Award
    Sydney Tang Speaker The University of Hong KongHong Kong, China
  • Excellence in Basic Science Award
    Ming LI Speaker Guangdong Provincial People's HospitalChina
  • President APSN - Introduction of Haiyan Wang Lecture
    Sydney Tang Speaker The University of Hong KongHong Kong, China
  • Haiyan Wang Lecture
    Somchai Eiam Ong Speaker Chulalongkorn Memorial Hospital Thailand
MR 110